Matthew R. Henn, Chief Scientific Officer en Executive Vice President bij Seres Therapeutics, Inc. (NASDAQ: MCRB ), heeft onlangs een reeks aandelentransacties uitgevoerd, volgens een melding bij de S ...

Nestle (NSRGY) faces growth challenges due to market saturation and competition. See why I maintain my hold rating for the ...

Nestlé‘s plans to focus on robust categories, like coffee and health science, reinforce its strategy to boost market ...

Bij recente transacties bij Seres Therapeutics, Inc. (NASDAQ: MCRB) heeft Teresa L. Young, de Executive Vice President, Chief Commercial & Strategy Officer, 3.338 gewone aandelen verkocht. Deze ...

"At the same time, the divestiture allows Nestle Health Science to focus on its core strengths and key growth drivers," he added. Nestle acquired Aimmune with high hopes that Palforzia would ...

Nestlé CEO Laurent Freixe has suggested the world's largest food maker is “immune” to tariffs due to the shape of its manufacturing footprint. US President Donald Trump has threatened tariffs ...

Laurent Freixe, Nestlé CEO commented: “In a challenging macroeconomic context and soft consumer environment, we achieved a solid performance in 2024 in line with our latest guidance. Organic growth ...